American Cryostem Corp (fka CRYO)

[236T568]

huh?

what simple hurdle?

a 44% drop in revenues mostly due to stoppage of all shipments of this main product, leading to massive Net Losses.

5 months later, CRYO has yet to accomplish this "simple hurdle" with the FDA for one of its main products and continues to stop shipments of all of these products

the June 30th quarter will be even worse than this quarter just reported

this is NOT a good thing

The reason being the FDA ... means it's simply a hurdle to accomplish and once it is accomplished we have much to look forward to. CRYO's continued presence at The Aesthetic Meeting 2018 in New York, NY is a strong indicator of FDA requirements progress:
www.irdirect.net/prviewer/release/id/3070728

NOTICE IN THE 'ABOUT' PARAGRAPH THE WORDS "FDA registered" which cannot be used lightly or without signification:

About American CryoStem Corporation
American CryoStem Corporation (OTC:CRYO); founded in 2008, is a biotechnology pioneer, standardizing adipose tissue (fat) derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The Company operates a state-of-art, FDA-registered, laboratory in New Jersey.... (underline mine)

NO POST OF MINE IS EVER TO BE CONTRUED TO BE A RECOMMENDATION TO BUY OR SELL ANY STOCK OR COMMODITY. NEITHER TO PARTICIPATE IN STOCK MARKET ACTIVITY AT ALL. I AM A NOVICE AND THIS IS ONLY WHAT I SEE.